Soft-tissue filler complications: The important role of biofilms

Plastic and Reconstructive Surgery

Volumn 125, Issue 4, 2010, Pages 1250-1256

  Rohrich, Rod J ^a   Monheit, Gary ^b   Nguyen, Alexander T ^b   Brown, Spencer A ^b   Fagien, Steven ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL;

ALGORITHM; ARTICLE; BIOFILM; ESTHETIC SURGERY; FOREIGN BODY GRANULOMA; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGY; REJUVENATION; RISK FACTOR; SOFT TISSUE INFECTION;

ALGORITHMS; BIOCOMPATIBLE MATERIALS; BIOFILMS; COSMETIC TECHNIQUES; GRANULOMA, FOREIGN-BODY; HUMANS; REJUVENATION; RISK FACTORS; SOFT TISSUE INFECTIONS;

EID: 77951026740     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181cb4620     Document Type: Article

References (50)

1. von Leeuwenhoek A. An abstract of a letter from Mr. Anthony Leevvenhoek at Delft, dated Sepember 17, 1683, Containing Some Microscopical Observations, about Animals in the Scurf of the Teeth, the Substance Call'd Worms in the Nose, the Cuticula Consisting of Scales. Philosophical Transactions 1684;14:568-574.
2. Costerton JW, Geesey GG, Cheng KJ. How bacteria stick. Sci Am. 1978;238:86-95.
3. Heukelekian H, Heller A. Relation between food concentration and surface for bacterial growth. J Bacteriol. 1940;40: 547-558.
4. Biofim (Wikipedia web site). Available at: http://en.wikipedia. org/wiki/Biofilm. Accessed January 25, 2009.
5. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: From the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2:95-108.
6. Donlan R. Biofilms: Microbial life on surfaces. Emerg Infect Dis. 2002;8:891-1890
7. Rohrich RJ, Nguyen AT, Kenkel JM. Lexicon for soft tissue implants. Dermatol Surg. 2009;35:1605-1611.
8. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science 1999;284: 1318-1322.
9. Shiau AL, Wu CL. The inhibitory effect of Staphylococcus epidermidis slime on the phagocytosis of murine peritoneal macrophages is interferon-independent. Microbiol Immunol. 1998;42:33-40.
10. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 1999;37:1771-1776.
11. Anwar H, Strap JL, Chen K, Costerton JW. Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin. Antimicrob Agents Chemother. 1992;36:1208-1214.
12. Ghigo JM. Natural conjugative plasmids induce bacterial biofilm development. Nature 2001;412:442-445.
13. Stickler DJ, Morris NS, McLean RJ, Fuqua C. Biofilms on indwelling urethral catheters produce quorum-sensing signal molecules in situ and in vitro. Appl Environ Microbiol. 1998;64:3486-3490.
14. Flemming HC. Biofouling in water systems: Cases, causes and countermeasures. Appl Microbiol Biotechnol. 2002;59:629-640.
15. Davis SC, Ricotti C, Cazzaniga A, Welsh E, Eaglstein WH, Mertz PM. Microscopic and physiologic evidence for biofilmassociated wound colonization in vivo. Wound Repair Regen. 2008;16:23-29.
16. Harrison-Balestra C, Cazzaniga AL, Davis SC, Mertz PM. A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualized by light microscopy. Dermatol Surg. 2003;29:631-635.
17. Archibald LK, Gaynes RP. Hospital-acquired infections in the United States: The importance of interhospital comparisons. Infect Dis Clin North Am. 1997;11:245-255.
18. Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 2001;9:34-39.
19. Parsek MR, Singh PK. Bacterial biofilms: An emerging link to disease pathogenesis. Annu Rev Microbiol. 2003;57:677-701.
20. Rohrich RJ, Rios JL, Fagien S. Role of new fillers in facial rejuvenation: A cautious outlook. Plast Reconstr Surg. 2003; 112:1899-1902.
21. Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg. 2005;29:34-48.
22. American Society of Plastic Surgeons. National Clearinghouse of Plastic Surgery Statistics. Available at: http://www. plasticsurgery.org/media/press- releases/injectables-at-aglance. cfm. Accessed January 25, 2009.
23. American Society for Dermatologic Surgery. American Society for Dermatologic Surgery procedure survey data. Available at: http://www.asds.net/ TheAmericanSocietyforDermatologic SurgeryReleasesNewProcedureSurveyData.aspx. Accessed January 25, 2009.
24. Broder KW, Cohen SR. An overview of permanent and semipermanent fillers. Plast Reconstr Surg. 2006;118:7S-14S.
25. Matarasso SL. Injectable collagens: Lost but not forgotten. A review of products, indications, and injection techniques. Plast Reconstr Surg. 2007;120:17S-26S.
26. Alam M, Dover JS. Management of complications and sequelae with temporary injectable fillers. Plast Reconstr Surg. 2007;120:98S-105S.
27. Cohen JL. Understanding, avoiding, and managing dermal filler complications. Dermatol Surg. 2008;34(Suppl 1):S92-S99.
28. Lemperle G, Rullan PP, Gauthier-Hazan N. Avoiding and treating dermal filler complications. Plast Reconstr Surg. 2006; 118:92S-107S.
29. Lowe NJ, Maxwell CA, Patnaik R. Adverse reactions to dermal fillers: Review. Dermatol Surg. 2005;31:1616-1625.
30. Andre P, Lowe NJ, Parc A, Clerici TH, Zimmermann U. Adverse reactions to dermal fillers: A review of European experiences. J Cosmet Laser Ther. 2005;7:171-176.
31. Parada MB, Michalany NS, Hassun KM, Bagatin E, Talarico S. A histologic study of adverse effects of different cosmetic skin fillers. Skinmed 2005;4:345-349.
32. Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg. 2003;27:354-366; discussion 367.
33. Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29:588-595.
34. Glaich AS, Cohen JL, Goldberg LH. Injection necrosis of the glabella: Protocol for prevention and treatment after use of dermal fillers. Dermatol Surg. 2006;32:276-281.
35. McCleve DE, Goldstein JC. Blindness secondary to injections in the nose, mouth, and face: Cause and prevention. Ear Nose Throat J. 1995;74:182-188.
36. Mullins RJ, Richards C, Walker T. Allergic reactions to oral, surgical and topical bovine collagen: Anaphylactic risk for surgeons. Aust N Z J Ophthalmol. 1996;24:257-260.
37. Narins RS, Jewell M, Rubin M, Cohen J, Strobos J. Clinical conference: Management of rare events following dermal fillers: Focal necrosis and angry red bumps. Dermatol Surg. 2006;32:426-434.
38. Kumar V, Abbas AK, Fausto N, et al. Robbins and Cotran Pathologic Basis of Disease. 7th ed. Philadelphia: Elsevier Saunders, 2005.
39. Dadzie OE, Mahalingam M, Parada M, El Helou T, Philips T, Bhawan J. Adverse cutaneous reactions to soft tissue fillers: A review of the histological features. J Cutan Pathol. 2008; 35:536-548.
40. Gelfer A, Carruthers A, Carruthers J, Jang F, Bernstein SC. The natural history of polymethylmethacrylate microspheres granulomas. Dermatol Surg. 2007;33:614-620.
41. Achauer BM. A serious complication following medicalgrade silicone injection of the face. Plast Reconstr Surg. 1983; 71:251-254.
42. Rongioletti F, Cattarini G, Sottofattori E, Rebora A. Granulomatous reaction after intradermal injections of hyaluronic acid gel. Arch Dermatol. 2003;139:815-816.
43. Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg. 2003;29:573-587; discussion 587.
44. Hoffmann N, Lee B, Hentzer M, et al. Azithromycin blocks quorum sensing and alginate polymer formation and in- creases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice. Antimicrob Agents Chemother. 2007;51:3677-3687.
45. Lambros V. The use of hyaluronidase to reverse the effects of hyaluronic acid filler. Plast Reconstr Surg. 2004;114:277.
46. Wolcott RD, Ehrlich GD. Biofilms and chronic infections. JAMA. 2008;299:2682-2684.
47. Johansen C, Falholt P, Gram L. Enzymatic removal and disinfection of bacterial biofilms. Appl Environ Microbiol. 1997; 63:3724-3728.
48. Smith KM, Bu Y, Suga H. Induction and inhibition of Pseudomonas aeruginosa quorum sensing by synthetic autoinducer analogs. Chem Biol. 2003;10:81-89.
49. Lichter JA, Thompson MT, Delgadillo M, Nishikawa T, Rubner MF, Van Vliet KJ. Substrata mechanical stiffness can regulate adhesion of viable bacteria. Biomacromolecules 2008; 9:1572-1578.
50. Kollef MH, Afessa B, Anzueto A, et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: The NASCENT randomized trial. JAMA. 2008;300: 805-813.